The Journal of Immunology, Vol 155, Issue 10 4829-4837, Copyright © 1995 by American Association of Immunologists

ARTICLES

Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock

JD Mountz, TJ Baker, DR Borcherding, H Bluethmann, T Zhou and CK Edwards 3rd
Department of Medicine, University of Alabama at Birmingham, USA.

MRL-lpr/lpr mice are defective in the fas Ag/APO-1 apoptosis gene (CD95). Using the hepatotoxin D-galactosamine (D-GalNH2), we demonstrate that MRL-lpr/lpr mice have an increased susceptibility to staphylococcal enterotoxin B (SEB)-induced lethal shock, which causes them to exhibit the septic shock-like behaviors of fur ruffling and listlessness, and death occurs within 8 to 18 h. SEB susceptibility is greater in V beta 8.2 TCR transgenic MRL-lpr/lpr mice than in nontransgenic mice. In studies designed to elucidate the molecular pathways of SEB-induced septic shock, we found that C57Bl/6.Ab0/Ab0, MHC class II-deficient "C2D" mice, but not C57Bl/6-(+/+) mice, are nonresponsive to challenge with SEB. C2D mice, backcrossed with the fas mutation resulting in double-knockout C2D;lpr/lpr mice, are more susceptible to challenge with SEB/D-GalNH2. The LD50s for C57Bl/6.C3H- gld/gld "fas ligand-mutant mice" challenged with SEB/D-GalNH2 were comparable to C57Bl/6.MRL-lpr/lpr and MRL-lpr/lpr mice, suggesting that reciprocal mutations in either fas or fas ligand increases susceptibility to bacterial superantigens (SAGs). SEB-induced lethal shock can be reversed by treatment with Abs to V beta 8 TCR, MHC class II Ia+, IL-2, and TNF-alpha, by the immunosuppressant cyclosporin A, or by treatment with carbocyclic nucleoside analogues. These data indicate that SAG-induced septic shock is dependent on interactions with the TCR and MHC class II Ags, and they also suggest a critical role for a functional fas and/or fas ligand in resistance to SAG-induced septic shock.

This article has been cited by other articles:

				K. Hayashida, Y. Chen, A. H. Bartlett, and P. W. Park Syndecan-1 Is an in Vivo Suppressor of Gram-positive Toxic Shock J. Biol. Chem., July 18, 2008; 283(29): 19895 - 19903. [Abstract] [Full Text] [PDF]

				M. Soller, A. Tautenhahn, B. Brune, K. Zacharowski, S. John, H. Link, and A. von Knethen Peroxisome proliferator-activated receptor {gamma} contributes to T lymphocyte apoptosis during sepsis J. Leukoc. Biol., January 1, 2006; 79(1): 235 - 243. [Abstract] [Full Text] [PDF]

				L. Faulkner, A. Cooper, C. Fantino, D. M. Altmann, and S. Sriskandan The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm J. Immunol., November 15, 2005; 175(10): 6870 - 6877. [Abstract] [Full Text] [PDF]

				R. Silverstein Review: D-Galactosamine lethality model: scope and limitations Innate Immunity, June 1, 2004; 10(3): 147 - 162. [Abstract] [PDF]

				I. De Freitas, M. Fernandez-Somoza, E. Essenfeld-Sekler, and J. E. Cardier Serum Levels of the Apoptosis-Associated Molecules, Tumor Necrosis Factor-{alpha}/Tumor Necrosis Factor Type-I Receptor and Fas/FasL, in Sepsis Chest, June 1, 2004; 125(6): 2238 - 2246. [Abstract] [Full Text] [PDF]

				M. R. M. van den Brink, E. Moore, K. J. Horndasch, J. M. Crawford, J. Hoffman, G. F. Murphy, and S. J. Burakoff Fas-Deficient lpr Mice Are More Susceptible to Graft-Versus-Host Disease J. Immunol., January 1, 2000; 164(1): 469 - 480. [Abstract] [Full Text] [PDF]

				B. G. Stiles, Y. G. Campbell, R. M. Castle, and S. A. Grove Correlation of Temperature and Toxicity in Murine Studies of Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin 1 Infect. Immun., March 1, 1999; 67(3): 1521 - 1525. [Abstract] [Full Text] [PDF]

				J. Schumann, S. Angermuller, R. Bang, M. Lohoff, and G. Tiegs Acute Hepatotoxicity of Pseudomonas aeruginosa Exotoxin A in Mice Depends on T Cells and TNF J. Immunol., November 15, 1998; 161(10): 5745 - 5754. [Abstract] [Full Text] [PDF]

				R. W. G. Watson, O. D. Rotstein, M. Jimenez, J. Parodo, and J. C. Marshall Augmented Intracellular Glutathione Inhibits Fas-Triggered Apoptosis of Activated Human Neutrophils Blood, June 1, 1997; 89(11): 4175 - 4181. [Abstract] [Full Text] [PDF]